Indian billionaire Dilip Shanghvi’s plans to expand his healthcare empire in the U.S., the hantavirus outbreak on a cruise ...

Families with rare gene mutations that cause Alzheimer's in middle age are giving scientists a unique window on the disease, ...

The idea is straightforward: Take a blood test now, even without symptoms, and learn if you could some day develop ...

Scientists from Johns Hopkins Medicine report new evidence that clusters of brain tissue derived from the cells of patients with Alzheimer’s disease may be used to evaluate how ...

Medical Microinstruments (MMI) today announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE ...

Primary care clinicians with higher diagnostic confidence are adopting emerging blood-based Alzheimer’s disease tests, ...

Blood-based biomarkers, such as Roche’s pTau181 test, offer a powerful tool for identifying the right patients for Alzheimer’s disease clinical trials early. This October saw a landmark development in ...

Researchers at Washington University School of Medicine in St. Louis analyzed how long 282 Alzheimer’s patients were able to continue living independently after taking two specific treatments: ...

Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell continue their ...

In "Beyond Diagnosis: Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell discuss how to communicate effectively with patients and families ...

Research reveals why Alzheimer’s brain damage doesn’t always lead to dementia, highlighting the role of protective brain ...